UBS Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-600
Closed -$126 8942
2023
Q2
$126 Sell
600
-52,636
-99% -$11.1K ﹤0.01% 7387
2023
Q1
$8.52K Buy
53,236
+31,074
+140% +$4.97K ﹤0.01% 6620
2022
Q4
$12.4K Buy
22,162
+20,769
+1,491% +$11.6K ﹤0.01% 7087
2022
Q3
$2K Sell
1,393
-8,116
-85% -$11.7K ﹤0.01% 8736
2022
Q2
$6K Buy
+9,509
New +$6K ﹤0.01% 7735
2022
Q1
Sell
-6,312
Closed -$14K 9902
2021
Q4
$14K Sell
6,312
-10,833
-63% -$24K ﹤0.01% 7262
2021
Q3
$59K Buy
+17,145
New +$59K ﹤0.01% 5113
2021
Q2
Sell
-1,942
Closed -$6K 8751
2021
Q1
$6K Buy
1,942
+805
+71% +$2.49K ﹤0.01% 7227
2020
Q4
$2K Sell
1,137
-14,324
-93% -$25.2K ﹤0.01% 7113
2020
Q3
$18K Buy
15,461
+13,530
+701% +$15.8K ﹤0.01% 5539
2020
Q2
$2K Sell
1,931
-1,698
-47% -$1.76K ﹤0.01% 6824
2020
Q1
$3K Buy
+3,629
New +$3K ﹤0.01% 6617
2019
Q2
Sell
-1,526
Closed -$3K 7215
2019
Q1
$3K Sell
1,526
-6,012
-80% -$11.8K ﹤0.01% 6529
2018
Q4
$9K Buy
7,538
+522
+7% +$623 ﹤0.01% 6375
2018
Q3
$19K Buy
7,016
+5,353
+322% +$14.5K ﹤0.01% 5916
2018
Q2
$3K Buy
+1,663
New +$3K ﹤0.01% 6737
2018
Q1
Sell
-100
Closed 7133
2017
Q4
$0 Sell
100
-200
-67% ﹤0.01% 7037
2017
Q3
$0 Hold
300
﹤0.01% 6960
2017
Q2
$0 Sell
300
-200
-40% ﹤0.01% 6925
2017
Q1
$2K Sell
500
-15,591
-97% -$62.4K ﹤0.01% 6386
2016
Q4
$22K Buy
16,091
+15,291
+1,911% +$20.9K ﹤0.01% 5523
2016
Q3
$1K Sell
800
-6,269
-89% -$7.84K ﹤0.01% 6602
2016
Q2
$9K Buy
7,069
+4,769
+207% +$6.07K ﹤0.01% 5960
2016
Q1
$12K Sell
2,300
-128,764
-98% -$672K ﹤0.01% 5707
2015
Q4
$1.03M Buy
131,064
+128,639
+5,305% +$1.01M ﹤0.01% 2673
2015
Q3
$20K Buy
2,425
+674
+38% +$5.56K ﹤0.01% 5448
2015
Q2
$19K Buy
1,751
+251
+17% +$2.72K ﹤0.01% 5539
2015
Q1
$21K Buy
1,500
+1,000
+200% +$14K ﹤0.01% 5356
2014
Q4
$8K Buy
+500
New +$8K ﹤0.01% 6138